• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗可改善有症状心力衰竭患者的心率变异性。

Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure.

作者信息

Adamson Philip B, Kleckner Karen J, VanHout Warren L, Srinivasan Sriram, Abraham William T

机构信息

Department of Internal Medicine, Cardiovascular Disease Section, University of Oklahoma Health Sciences Center, PO Box 26901, 920 SL Young Boulevard, WP3120, Oklahoma City, Okla 73104, USA.

出版信息

Circulation. 2003 Jul 22;108(3):266-9. doi: 10.1161/01.CIR.0000083368.75831.7A. Epub 2003 Jul 14.

DOI:10.1161/01.CIR.0000083368.75831.7A
PMID:12860899
Abstract

BACKGROUND

Cardiac resynchronization therapy (CRT) using biventricular pacing improves symptoms and functional capacity in patients with moderate to severe heart failure. The present study examined whether an improvement in ventricular performance from resynchronization therapy changes the autonomic control of heart rate.

METHODS AND RESULTS

Heart rate variability (HRV) was examined in 50 patients implanted with the InSync biventricular pacing system who were randomized to therapy-on (n=25) or therapy-off (n=25). HRV was computed as the standard deviation of the atrial cycle length sensed from the system over 2 months of continuous monitoring. HRV was compared between CRT-on and CRT-off groups. HRV was higher in patients randomized to CRT-on compared with CRT-off (148+/-47 ms for CRT-on versus 118+/-45 ms for CRT-off; P=0.02), despite the lack of difference in mean atrial cycle length (844+/-129 ms for CRT-on versus 851+/-110 ms for CRT-off; P=0.82). Changes in plasma catecholamines were not different between the CRT-on and CRT-off groups from baseline to the 3-month follow-up.

CONCLUSIONS

Improvement in ventricular performance from CRT shifts cardiac autonomic balance toward a more favorable profile that is less dependent on sympathetic activation.

摘要

背景

使用双心室起搏的心脏再同步治疗(CRT)可改善中重度心力衰竭患者的症状和功能能力。本研究探讨了再同步治疗引起的心室功能改善是否会改变心率的自主控制。

方法与结果

对50例植入InSync双心室起搏系统的患者进行心率变异性(HRV)检测,这些患者被随机分为治疗开启组(n = 25)和治疗关闭组(n = 25)。HRV通过在连续监测的2个月内从系统感知到的心房周期长度的标准差来计算。比较CRT开启组和CRT关闭组的HRV。随机分配到CRT开启组的患者的HRV高于CRT关闭组(CRT开启组为148±47毫秒,CRT关闭组为118±45毫秒;P = 0.02),尽管平均心房周期长度没有差异(CRT开启组为844±129毫秒,CRT关闭组为851±110毫秒;P = 0.82)。从基线到3个月随访,CRT开启组和CRT关闭组的血浆儿茶酚胺变化没有差异。

结论

CRT引起的心室功能改善使心脏自主神经平衡向更有利的状态转变,这种状态对交感神经激活的依赖性较小。

相似文献

1
Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure.心脏再同步治疗可改善有症状心力衰竭患者的心率变异性。
Circulation. 2003 Jul 22;108(3):266-9. doi: 10.1161/01.CIR.0000083368.75831.7A. Epub 2003 Jul 14.
2
Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure.心脏再同步治疗可改善中重度心力衰竭患者的心率模式和心率变异性。
J Am Coll Cardiol. 2005 Nov 15;46(10):1875-82. doi: 10.1016/j.jacc.2005.06.081. Epub 2005 Oct 24.
3
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.晚期慢性心力衰竭患者联合心脏再同步化治疗与植入式心脏复律除颤治疗:MIRACLE ICD试验
JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685.
4
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.心脏再同步治疗对慢性心力衰竭患者左心室大小及功能的影响。
Circulation. 2003 Apr 22;107(15):1985-90. doi: 10.1161/01.CIR.0000065226.24159.E9. Epub 2003 Mar 31.
5
Atrial pacing and sensing characteristics in heart failure patients undergoing cardiac resynchronization therapy.接受心脏再同步治疗的心力衰竭患者的心房起搏和感知特性。
Europace. 2005 Mar;7(2):165-9. doi: 10.1016/j.eupc.2004.12.004.
6
Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.心脏再同步治疗对充血性心力衰竭患者疾病进展的影响。
Ital Heart J. 2004 May;5(5):364-70.
7
Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.心房和室性早搏的频率与双心室起搏比例与心脏再同步治疗患者预后的关系。
J Am Coll Cardiol. 2014 Sep 9;64(10):971-81. doi: 10.1016/j.jacc.2014.06.1177.
8
Predictors of a positive response to biventricular pacing in patients with severe heart failure and ventricular conduction delay.重度心力衰竭合并心室传导延迟患者对双心室起搏产生阳性反应的预测因素。
Pacing Clin Electrophysiol. 2007 Aug;30(8):970-5. doi: 10.1111/j.1540-8159.2007.00794.x.
9
A novel algorithm for individualized cardiac resynchronization therapy: rationale and design of the adaptive cardiac resynchronization therapy trial.一种新的个体化心脏再同步治疗算法:适应性心脏再同步治疗试验的原理和设计。
Am Heart J. 2012 May;163(5):747-752.e1. doi: 10.1016/j.ahj.2012.02.007.
10
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacing.右心房起搏在心脏再同步治疗期间会损害心脏功能:DDD起搏与VDD起搏的急性效应比较。
J Am Coll Cardiol. 2005 May 3;45(9):1482-7. doi: 10.1016/j.jacc.2005.01.033.

引用本文的文献

1
Optimal effectiveness of heart failure management - an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure.心力衰竭管理的最佳效果 - 荟萃分析的综合评价,考察了减少心力衰竭再住院的干预措施的有效性。
Heart Fail Rev. 2022 Sep;27(5):1683-1748. doi: 10.1007/s10741-021-10212-8. Epub 2022 Mar 3.
2
Remote monitoring and telemedicine in heart failure: implementation and benefits.心力衰竭的远程监测与远程医疗:实施与益处
Curr Cardiol Rep. 2021 May 7;23(6):55. doi: 10.1007/s11886-021-01487-2.
3
Pacing at accelerated heart rate during echocardiography-guided atrioventricular optimisation following cardiac resynchronisation therapy.
心脏再同步治疗后超声心动图引导下房室优化期间的心率加速起搏
Arch Med Sci Atheroscler Dis. 2020 Sep 10;5:e230-e236. doi: 10.5114/amsad.2020.98928. eCollection 2020.
4
Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.充血性心力衰竭合并心房颤动时的房室结导管消融术
J Atr Fibrillation. 2018 Jun 30;11(1):1813. doi: 10.4022/jafib.1813. eCollection 2018 Jun-Jul.
5
Atrial Fibrillation Complicating Congestive Heart Failure: Electrophysiological Aspects And Its Deleterious Effect On Cardiac Resynchronization Therapy.心房颤动合并充血性心力衰竭:电生理方面及其对心脏再同步治疗的有害影响。
J Atr Fibrillation. 2009 Jun 1;2(1):143. doi: 10.4022/jafib.143. eCollection 2009 Jun-Jul.
6
Exercise training improves neurovascular control and calcium cycling gene expression in patients with heart failure with cardiac resynchronization therapy.运动训练可改善接受心脏再同步治疗的心力衰竭患者的神经血管控制和钙循环基因表达。
Am J Physiol Heart Circ Physiol. 2016 Nov 1;311(5):H1180-H1188. doi: 10.1152/ajpheart.00275.2016. Epub 2016 Sep 2.
7
[Implantable hemodynamic monitoring devices].
Herz. 2015 Nov;40(7):966-71. doi: 10.1007/s00059-015-4363-7.
8
The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.射血分数降低的心力衰竭中的交感神经/副交感神经失衡。
Eur Heart J. 2015 Aug 7;36(30):1974-82b. doi: 10.1093/eurheartj/ehv087. Epub 2015 May 13.
9
Glycoproteins identified from heart failure and treatment models.从心力衰竭和治疗模型中鉴定出的糖蛋白。
Proteomics. 2015 Jan;15(2-3):567-79. doi: 10.1002/pmic.201400151. Epub 2014 Oct 9.
10
Potential pro-arrhythmic effect of cardiac resynchronization therapy.心脏再同步治疗的潜在促心律失常作用。
J Saudi Heart Assoc. 2013 Jul;25(3):181-9. doi: 10.1016/j.jsha.2013.05.002. Epub 2013 May 30.